Spots Global Cancer Trial Database for locally advanced pancreatic adenocarcinoma
Every month we try and update this database with for locally advanced pancreatic adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Pressure Enabled Intrapancreatic Delivery of SD-101 With Checkpoint Blockade for Locally Advanced Pancreatic Adenocarcinoma | NCT05607953 | Locally Advance... | SD-101 anti-PD-1 | 18 Years - | TriSalus Life Sciences, Inc. | |
| Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advance or Metastatic Pancreatic Cancer | NCT06381154 | Locally Advance... Metastatic Panc... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa... | Biopsy Biospecimen Col... Computed Tomogr... Endoscopic Ultr... Fluorouracil Irinotecan Leucovorin Lymph Node Biop... Magnetic Resona... Oxaliplatin Pembrolizumab Photodynamic Th... Positron Emissi... Questionnaire A... Verteporfin | 18 Years - | Mayo Clinic | |
| Anlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic Cancer | NCT04718701 | Pancreatic Neop... Metastatic Panc... Locally Advance... | Anlotinib+Torip... | 18 Years - 75 Years | The First Affiliated Hospital with Nanjing Medical University | |
| Immunochemoradiotherapy in Patients With Pancreatic Cancer | NCT01342224 | Locally Advance... | tadalafil and v... | 18 Years - | Providence Health & Services | |
| Clinical Trial to Investigate Safety, Tolerability and MTD for SCO-101 in Combination With Gemcitabine and Nab-paclitaxel in Inoperable Pancreatic Cancer Patients. | NCT04652206 | Metastatic Panc... Locally Advance... Inoperable Dise... Localized Pancr... | SCO-101 Gemcitabine Nab paclitaxel | 18 Years - | Scandion Oncology A/S | |
| Anlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic Cancer | NCT04718701 | Pancreatic Neop... Metastatic Panc... Locally Advance... | Anlotinib+Torip... | 18 Years - 75 Years | The First Affiliated Hospital with Nanjing Medical University | |
| BATs Treatment for Pancreatic Cancer, Phase Ib/II | NCT03269526 | Locally Advance... Metastatic Panc... | EGFR BATs after... | 18 Years - | University of Virginia | |
| Effect Of Preoperative Chemotherapy On Short-Term Outcome After Pancreatic Resection | NCT01278368 | Locally Advance... | Pancreatic rese... Pancreatic rese... | 18 Years - 80 Years | Università Vita-Salute San Raffaele | |
| Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | NCT01585805 | Locally Advance... Metastatic Panc... Stage III Pancr... Stage IV Pancre... | Biopsy Biospecimen Col... Cisplatin Computed Tomogr... Gemcitabine Gemcitabine Hyd... Magnetic Resona... Veliparib | 18 Years - | National Cancer Institute (NCI) | |
| Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer | NCT04423731 | Locally Advance... Chemotherapy Ef... Borderline Rese... Pancreatectomy | Folfirinox | 18 Years - | Oslo University Hospital | |
| Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma | NCT05825066 | Pancreas Adenoc... Borderline Rese... Locally Advance... | Nab paclitaxel Gemcitabine Radiological As... mFOLFIRINOX | 18 Years - | Wake Forest University Health Sciences | |
| OncoSil Pancreatic Cancer Post-marketing Clinical Registry - Italy | NCT06399172 | Locally Advance... | OncoSil | 18 Years - | OncoSil Medical Limited | |
| Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer | NCT05356039 | Pancreas Cancer Pancreas Neopla... Pancreas Diseas... Pancreas Adenoc... Surgery Chemotherapy Ef... Quality of Life Locally Advance... Borderline Rese... | 18 Years - | Umeå University | ||
| Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3) | NCT03377491 | Pancreas Adenoc... | NovoTTF-200T Gemcitabine nab paclitaxel | 18 Years - | NovoCure Ltd. | |
| Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | NCT01585805 | Locally Advance... Metastatic Panc... Stage III Pancr... Stage IV Pancre... | Biopsy Biospecimen Col... Cisplatin Computed Tomogr... Gemcitabine Gemcitabine Hyd... Magnetic Resona... Veliparib | 18 Years - | National Cancer Institute (NCI) | |
| Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer | NCT05679674 | Pancreas Cancer Locally Advance... Locally Advance... | Stereotactic Ab... Tumor Treating ... | 18 Years - | Baptist Health South Florida | |
| PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer | NCT05524090 | Pancreatic Canc... Locally Advance... Pancreatic Aden... Chemotherapy Ef... | Implementation ... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery | NCT00669734 | Locally Advance... Pancreatic Acin... Pancreatic Duct... Stage III Pancr... Stage IV Pancre... | Falimarev Inalimarev Laboratory Biom... Sargramostim | 18 Years - | National Cancer Institute (NCI) | |
| Trial of Carbon Ion Versus Photon Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer | NCT03536182 | Locally Advance... | Carbon Ion Radi... Intensity Modul... | 18 Years - 120 Years | University of Texas Southwestern Medical Center | |
| Locally Advanced Pancreatic Cancer After Systemic Therapy: Ablative MR-guided Radiotherapy | NCT06272162 | Locally Advance... | MR guided radio... | 18 Years - | UMC Utrecht | |
| Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer | NCT05034627 | Locally Advance... Metastatic Panc... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre... | Biopsy Calaspargase Pe... Cobimetinib | 18 Years - | OHSU Knight Cancer Institute | |
| Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to Radiation Therapy for Localized Pancreatic Cancer | NCT04172532 | Locally Advance... Locally Advance... Stage II Pancre... Stage III Pancr... Unresectable Pa... | Biopsy Biospecimen Col... Computed Tomogr... Hypofractionate... Magnetic Resona... Peposertib Placebo Adminis... | 18 Years - | National Cancer Institute (NCI) | |
| Phase II/III of Randomized Controlled Clinical Research on IRE Synchronous Chemotherapy for LAPC | NCT03673137 | Locally Advance... | Irreversible el... Gemcitabine | 18 Years - 75 Years | Fuda Cancer Hospital, Guangzhou | |
| FAZA PET/MRI Pancreas | NCT04395469 | Pancreatic Aden... Locally Advance... Unresectable Pa... | 18F-FAZA | 18 Years - | University Health Network, Toronto | |
| PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer | NCT05524090 | Pancreatic Canc... Locally Advance... Pancreatic Aden... Chemotherapy Ef... | Implementation ... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| Role of Interim 18F-FLT PET/CT for Outcome Prediction in Pancreatic Adenocarcinoma | NCT03318497 | Pancreatic Aden... | 3'-deoxy-3'-[F-... Computed Tomogr... Positron Emissi... Laboratory Biom... | 18 Years - | University of Texas Southwestern Medical Center | |
| Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer | NCT05356039 | Pancreas Cancer Pancreas Neopla... Pancreas Diseas... Pancreas Adenoc... Surgery Chemotherapy Ef... Quality of Life Locally Advance... Borderline Rese... | 18 Years - | Umeå University | ||
| Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer | NCT05356039 | Pancreas Cancer Pancreas Neopla... Pancreas Diseas... Pancreas Adenoc... Surgery Chemotherapy Ef... Quality of Life Locally Advance... Borderline Rese... | 18 Years - | Umeå University | ||
| Anlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic Cancer | NCT04718701 | Pancreatic Neop... Metastatic Panc... Locally Advance... | Anlotinib+Torip... | 18 Years - 75 Years | The First Affiliated Hospital with Nanjing Medical University | |
| Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma | NCT03077685 | Locally Advance... | NanoPac® | 18 Years - | NanOlogy, LLC | |
| Pressure Enabled Intrapancreatic Delivery of SD-101 With Checkpoint Blockade for Locally Advanced Pancreatic Adenocarcinoma | NCT05607953 | Locally Advance... | SD-101 anti-PD-1 | 18 Years - | TriSalus Life Sciences, Inc. | |
| Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydrochloroquine as Treatment in Untreated Pancreas Cancer | NCT04669197 | Untreated Resec... Borderline Rese... Locally Advance... | Paclitaxel prot... Gemcitabine Cisplatin Hydroxychloroqu... | 18 Years - | HonorHealth Research Institute | |
| Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advance or Metastatic Pancreatic Cancer | NCT06381154 | Locally Advance... Metastatic Panc... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa... | Biopsy Biospecimen Col... Computed Tomogr... Endoscopic Ultr... Fluorouracil Irinotecan Leucovorin Lymph Node Biop... Magnetic Resona... Oxaliplatin Pembrolizumab Photodynamic Th... Positron Emissi... Questionnaire A... Verteporfin | 18 Years - | Mayo Clinic | |
| Phase II/III of Randomized Controlled Clinical Research on IRE Synchronous Chemotherapy for LAPC | NCT03673137 | Locally Advance... | Irreversible el... Gemcitabine | 18 Years - 75 Years | Fuda Cancer Hospital, Guangzhou | |
| Clinical Trial to Investigate Safety, Tolerability and MTD for SCO-101 in Combination With Gemcitabine and Nab-paclitaxel in Inoperable Pancreatic Cancer Patients. | NCT04652206 | Metastatic Panc... Locally Advance... Inoperable Dise... Localized Pancr... | SCO-101 Gemcitabine Nab paclitaxel | 18 Years - | Scandion Oncology A/S | |
| FAZA PET/MRI Pancreas | NCT04395469 | Pancreatic Aden... Locally Advance... Unresectable Pa... | 18F-FAZA | 18 Years - | University Health Network, Toronto | |
| First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer | NCT04665947 | Metastatic Panc... Locally Advance... | [68Ga]Ga DOTA-5... | 18 Years - | University of California, Davis |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
